Zainab Rai

Dr. Zainab Rai

Wellcome/EPSRC center for interventional and surgical sciences (WEISS)
+1
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ZRZainab Rai
Zainab Rai
RFRoger Feakins
Roger Feakins
LPLaura Pallett
Laura Pallett
Derek ManasDerek Manas
Derek Manas
Brian DavidsonBrian Davidson
Brian Davidson
Locally advanced pancreatic cancer (LAPC) accounts for 30% of patients with pancreatic cancer. Irreversible electroporation (IRE) is a novel cancer treatment that may improve survival and quality of life in LAPC. This narrative review will provide a perspective on the clinical experience of pancreas IRE therapy, explore the evidence for the mode of action, assess treatment complications, and propose strategies for augmenting IRE response. A systematic search was performed using PubMed regarding the clinical use and safety profile of IRE on pancreatic cancer, post-IRE sequential histological changes, associated immune response, and synergistic therapies. Animal data demonstrate that IRE induces both apoptosis and necrosis followed by fibrosis. Major complications may result from IRE; procedure related mortality is up to 2%, with an average morbidity as high as 36%. Nevertheless, prospective and retrospective studies suggest that IRE treatment may increase median overall survival of LAPC to as much as 30 months and provide preliminary data justifying the well-designed trials currently underway, comparing IRE to the standard of care treatment. The mechanism of action of IRE remains unknown, and there is a lack of data on treatment variables and efficiency in humans. There is emerging data suggesting that IRE can be augmented with synergistic therapies such as immunotherapy.

1 November 2018 in Respiratory Physiology & Neurobiology
Verified
Journal Article
Closed access
ZRZainab Rai
Zainab Rai
HFH.E. Fowles
H.E. Fowles
CWC. Wright
C. Wright
JHJoseph Howard
Joseph Howard
AMAlyn Morice
Alyn Morice

12 May 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
ZRZainab Rai
Zainab Rai
VRVeronica Ranieri
Veronica Ranieri
DPDaniel H Palmer
Daniel H Palmer
PLPeter Littler
Peter Littler
PGPauleh Ghaneh
Pauleh Ghaneh
BDBrian R Davidson
Brian R Davidson
Background Approximately 30% of patients with pancreas cancer have unresectable locally advanced disease, which is currently treated with systemic chemotherapy. A new treatment option of irreversible electroporation (IRE) has been investigated for these patients since 2005. Cohort studies suggest that IRE confers a survival advantage, but with associated, procedure-related complications. Selection bias may account for improved survival and there have been no prospective randomised trials evaluating the harms and benefits of therapy. The aim of this trial is to evaluate the feasibility of a randomised comparison of IRE therapy with chemotherapy versus chemotherapy alone in patients with locally advanced pancreatic cancer (LAPC). Methods and analysis Eligible patients with LAPC who have undergone first-line 5-FluoroUracil, Leucovorin, Irinotecan and Oxaliplatin chemotherapy will be randomised to receive either a single session of IRE followed by (if indicated) further chemotherapy or to chemotherapy alone (standard of care). Fifty patients from up to seven specialist pancreas centres in the UK will be recruited over a period of 15 months. Trial follow-up will be 12 months. The primary outcome measure is ability to recruit. Secondary objectives include practicality and technical success of treatment, acceptability of treatment to patients and clinicians and safety of treatment. A qualitative study has been incorporated to evaluate the patient and clinician perspective of the locally advanced pancreatic cancer with percutaneous irreversible electroporation trial. It is likely that the data obtained will guide the structure, the primary outcome measure, the power and the duration of a subsequent multicentre randomised controlled trial aimed at establishing the clinical efficiency of pancreas IRE therapy. Indicative procedure-related costings will be collected in this feasibility trial, which will inform the cost evaluation in the subsequent study on efficiency. Ethics and dissemination The protocol has received approval by London-Brent Research Ethics Committee reference number 21/LO/0077. Results will be analysed following completion of trial recruitment and follow-up. Results will be presented to international conferences with an interest in oncology, hepatopancreaticobiliary surgery and interventional radiology and be published in a peer-reviewed journal. Trial registration number ISRCTN14986389.

12 July 2023 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
ZRZainab Rai
Zainab Rai
MMMorenike Magbagbeola
Morenike Magbagbeola
KDKatie Doyle
Katie Doyle
LLLukas Lindenroth
Lukas Lindenroth
GDGeorge Dwyer
George Dwyer
Brian DavidsonBrian Davidson
Brian Davidson
Background: Machine perfusion (MP) is increasingly used for human transplant organ preservation. The use of MP for research purposes is another opportunity for this technology. The porcine pancreas and liver are similar in anatomical size and function to their human counterparts, making them an excellent resource for research, but they have some important differences from human organs which can influence their research use. In this paper, we describe a technique developed and tested for the retrieval of porcine organs for use in research on perfused viable organs. Methods: Whole-organ porcine pancreata and livers were harvested at a commercial abattoir, following standard slaughterhouse processes. The standard slaughterhouse process involved a thoracotomy and mid-line laparotomy, and all the thoracoabdominal organs were removed. The pancreas, fixed in the retroperitoneum, was carefully dissected from its attachments to the surrounding structures, and tissue planes between the pancreas, spleen, duodenum, and colon were meticulously identified and dissected. Vessel exposure and division: The aorta, portal vein (PV), hepatic vein (HV), and hepatic artery (HA) were dissected and isolated, preserving the input and output channels for the liver and pancreas. A distal 3 cm of the aorta was preserved and divided and served as the input for the pancreas perfusions. The liver, PV, HV, and HA were preserved and divided to preserve the physiological channels of the input (PV and HA) and output (HV) for the liver perfusions. The porcine hepatic and pancreas anatomy shares significant resemblance with the gross anatomy found in humans, and this was taken into consideration when designing the perfusion circuitry. The porcine pancreas and spleen shared a common blood supply, with branches arising from the splenic artery. The organs were flushed with cold, heparinised normal saline and transported in a temperature-regulated receptacle maintained at a core temperature between 4 and 8 °C, in line with the standards of static cold storage (SCS), to a dedicated perfusion lab and perfused using our novel perfusion machine with autologous, heparinised porcine blood, also collected at the abattoir.

5 July 2018
Verified
Book Chapter
Closed access
PDF file
ZRZainab Rai
Zainab Rai
AMAlyn Morice
Alyn Morice
PSPeter Sedman
Peter Sedman

11 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
ZRZainab Rai
Zainab Rai
NHNatalie Aroha Holroyd
Natalie Aroha Holroyd
MMMorenike Magbagbeola
Morenike Magbagbeola
EDEmre Doganay
Emre Doganay
KDKatie Doyle
Katie Doyle
BDBrian R Davidson
Brian R Davidson
Objectives: Machine perfusion of organs outside of the body is a growing area of research with significant applications in the fields of organ preservation and transplantation, but more widely it offers a new approach to study disease processes and to evaluate new therapeutics and devices. Magnetic Resonance Imaging (MRI) allows for non-invasive assessment of organ structure and function, enabling quantitative measurement of tissue perfusion and microstructure. In this study, we demonstrate that MR imaging sequences can be obtained from machine-perfused porcine livers using a modified perfusion rig for MR compatibility and highlight the quantitative measures that can be obtained through this methodology. Materials and Methods: 7 porcine livers were retrieved fresh from the abattoir using a previously published protocol and following transport in cold preservative underwent perfusion with oxygenated autologous blood inside a 3T clinical MRI scanner using a custom modified perfusion rig. Multiple MR imaging sequences were acquired: T2-weighted imaging, Diffusion Weighted Imaging and Dynamic Contrast Enhanced imaging following injection of Gadolinium dye into the portal vein and hepatic artery. Histological analysis was performed to assess preservation injury to the liver. Control samples for histology were obtained from livers with similar preservation periods but preserved in standard cold storage on ice (Static Cold Storage). Results: Concurrent MR imaging and machine perfusion were successfully performed, allowing dynamic measurement of tissue perfusion to be obtained in ex vivo livers, including calculation of gadolinium contrast enhancement curves and Apparent Diffusion Coefficient maps. Segmentation of vessels down to a radius of 0.45mm allowed detailed morphological analysis of the vascular network, including extraction of clinically relevant parameters such as vessel tortuosity. Histological evaluation showed better preservation of the hepatic acinar structure in perfused than non-perfused livers. Conclusions: Our results demonstrate that MR imaging of machine-perfused organs enables high-resolution quantitative evaluation of whole-organ vascular morphology and flow dynamics. This platform provides opportunities to study vascular pathology in diseased human organs and evaluate novel therapeutic interventions, with particular relevance for drug-delivery strategies.